Evaxion Biotech Files 6-K, Incorporates by Reference
Ticker: EVAX · Form: 6-K · Filed: Apr 7, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec, registration
Related Tickers: EVX
TL;DR
EVX files 6-K, rolls info into existing S-8/F-3/F-1 filings.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on April 7, 2025, for the month of April. This report is for a foreign private issuer and is incorporated by reference into several of Evaxion's existing registration statements on Forms S-8 and F-3, as well as multiple Form F-1 filings. The company is incorporated in G7 and its fiscal year ends on December 31.
Why It Matters
This filing indicates ongoing reporting requirements and the integration of information into existing securities offerings, which is standard for companies with multiple public filings.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain new material information or significant corporate events.
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- 001-39950 (dollar_amount) — Commission File Number
- 333-255064 (dollar_amount) — Form S-8 File Number
- 333-265132 (dollar_amount) — Form F-3 File Number
- 333-266050 (dollar_amount) — Form F-1 File Number
- 333-276505 (dollar_amount) — Form F-1 File Number
- 333-279153 (dollar_amount) — Form F-1 File Number
- 333-283304 (dollar_amount) — Form F-1 File Number
- 333-285778 (dollar_amount) — Form F-3 File Number
FAQ
What is the purpose of this Form 6-K filing by Evaxion Biotech A/S?
This Form 6-K is a report of a foreign private issuer for the month of April, serving to incorporate information by reference into existing registration statements.
Which registration statements does this 6-K filing get incorporated into?
It is incorporated into Evaxion Biotech A/S's registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), and multiple Form F-1 filings (File Nos. 333-266050, 333-276505, 333-279153, 333-283304), and Form F-3 (File No. 333-285778).
What is Evaxion Biotech A/S's Commission File Number?
Evaxion Biotech A/S's Commission File Number is 001-39950.
When is Evaxion Biotech A/S's fiscal year end?
Evaxion Biotech A/S's fiscal year ends on December 31.
Where is Evaxion Biotech A/S's principal executive office located?
Evaxion Biotech A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 7, 2025 regarding Evaxion Biotech A/S (EVAX).